March 20, 2018 / 12:12 PM / 4 months ago

BRIEF-Kempharm Announces Positive Topline Results From KP415 Pharmacokinetic Study In Children And Adolescents With ADHD

March 20 (Reuters) - Kempharm Inc:

* KEMPHARM ANNOUNCES POSITIVE TOPLINE RESULTS FROM KP415 PHARMACOKINETIC STUDY IN CHILDREN AND ADOLESCENTS WITH ADHD

* KEMPHARM INC - ‍ANTICIPATE ADDITIONAL CLINICAL DATA THROUGHOUT 2018, INCLUDING TOPLINE RESULTS FROM ON-GOING PIVOTAL EFFICACY STUDY BY MID-YEAR​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below